Hana Pharm Co., Ltd. (KRX:293480)

South Korea flag South Korea · Delayed Price · Currency is KRW
11,690
+10 (0.09%)
Last updated: Dec 5, 2025, 2:06 PM KST
7.64%
Market Cap 207.77B
Revenue (ttm) 139.33B
Net Income (ttm) 24.30B
Shares Out 17.77M
EPS (ttm) 2,243.00
PE Ratio 5.21
Forward PE n/a
Dividend 510.00 (4.36%)
Ex-Dividend Date Dec 27, 2024
Volume 13,509
Average Volume 16,872
Open 11,790
Previous Close 11,680
Day's Range 11,630 - 11,790
52-Week Range 10,050 - 12,500
Beta 0.33
RSI 55.87
Earnings Date Nov 14, 2025

About Hana Pharm

Hana Pharm Co., Ltd. develops and provides various pharmaceutical products in South Korea and internationally. It offers anesthetics, narcotic analgesics, antiemetics, muscle relaxants, cardiovascular and endocrine system, gastrointestinal system, respiratory system, antibiotics, dermatology, urinology, osteoporosis, and central nervous system products, as well as analgesics, antipyretics, and anti-inflammatory drugs. The company was founded in 1996 and is headquartered in Seoul, South Korea. [Read more]

Sector Healthcare
Founded 1996
Country South Korea
Stock Exchange Korea Stock Exchange
Ticker Symbol 293480
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.